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Abstract
Background: A long-term active surveillance of Q fever was conducted in Cyprus organized in
two phases.
Methods: Following serological tests and identification of seropositive humans and animals for C.
burnetii in two villages (VIL1 and VIL2), all seronegative individuals were followed up for one year
on a monthly basis by trained physicians to detect possible seroconversion for Q fever. In the
second phase of the study, active surveillance for one year was conducted in the entire Cyprus.
Physicians were following specific case definition criteria for Q fever. Standardized questionnaires,
a geographical information system on a regional level, Immunofluorescence Assay (IFA)
examinations and shell vial technique were used.
Results:  Eighty-one seronegative humans and 239 seronegative animals from both villages
participated in the first phase surveillance period of Q fever. Despite the small number of confirmed
clinical cases (2 humans and 1 goat), a significant percentage of new seropositives for C. burnetii
(44.4% of human participants and 13.8% of animals) was detected at the end of the year. During the
second phase of surveillance, 82 humans, 100 goats, and 76 sheep were considered suspected cases
of Q fever. However, only 9 human, 8 goat, and 4 sheep cases were serologically confirmed, while
C. burnetii was isolated from three human and two animal samples. The human incidence rate was
estimated at 1.2 per 100,000 population per year.
Conclusion: A small number of confirmed clinical cases of Q fever were observed despite the high
seroprevalence for C. burnetii in human and animal population of Cyprus. Most of the cases in the
local population of Cyprus appear to be subclinical. Moreover further studies should investigate the
role of ticks in the epidemiology of Q fever and their relation to human seropositivity.
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Background
Q fever, a zoonosis distributed worldwide, is caused by C.
burnetii and continues to be a public health problem in
the entire Mediterranean region. C. burnetii is an obligate
intracellular bacterium which lives in the phagolysosomes
of the host cells and its most important hosts are rumi-
nant animals (cows, sheep, goats) and domestic pets (cats,
dogs, rabbits). C. burnetii has been associated with infer-
tility and abortions in animals and is the causative agent
of acute and chronic human cases of Q fever with consid-
erable morbidity and mortality. Thus Q fever constitutes a
public health problem with significant socioeconomic
consequences [1-3].
Kaplan and Bertagna identified Q fever in Cyprus in 1951
for the first time [4]. During the years 1968 and 1969
Kelly examined 547 human blood samples from patients
of Nicosia's General Hospital and 5% were found positive
for C. burnetii. From December 1974 to June 1975, 78
British soldiers, who stationed in the Eastern Sovereign
Base Area (ESBA) in Cyprus, contracted Q fever [5]. Epide-
miological investigation revealed an abortion epidemic
involving 21 mixed flocks of sheep and goats in the south-
eastern coastal region. Eleven of the flocks grazed in and
around the ESBA. A serological survey of 10 affected flocks
indicated that the abortion epidemic was the result of
infection with C. burnetii. Transmission to humans was
almost certainly acquired by inhalation of contaminated
dust with C. burnetii after brushing birth products of the
aborting animals. However, in the same region and dur-
ing the same period no cases of Q fever were reported
from the local population.
Before the current study an epidemiological study was
conducted in Cyprus to estimate the seroprevalence for Q
fever and identify "high risk" regions by using a computer-
ized mapping program. The results of the above study are
reported elsewhere. To further investigate the epidemiol-
ogy of Q fever in Cyprus, we conducted the current study
by establishing active surveillance of Q fever, to detect
clinical cases in real time.
The main objectives of this study were to conduct active
surveillance of Q fever, initially in "high risk" regions of
Cyprus (VIL1 and VIL2) and afterwards in the entire
human and animal population of Cyprus, to detect acute
clinical cases of the disease and assess the pathogenicity of
C. burnetii. The overall aim of this study was to assess if the
small number of reported acute clinical cases of Q fever in
the local population of Cyprus, despite the high seroprev-
alence (52.7%) identified in previous studies, is due to
under diagnosis of Q fever or to under reporting of the dis-
ease.
Methods
Active surveillance of Q fever in the "high risk" region
Two villages of the rural area of Cyprus, VIL1 and VIL2,
were determined as "high risk" regions (high seropositiv-
ity for C. burnetii) during the previous seroprevalence
study. The entire population of both villages was invited
to participate in the study (150 inhabitants from VIL1 and
198 from VIL2). The size of the random animal sample
was calculated using an estimated 5% (± 3%) expected
prevalence for sheep and goats, and 5% (± 4%) for
bovine. All of the participants were initially serologically
examined and all seropositive for C. burnetii were
excluded from further follow up. Sera collected were
examined for the detection of IgG, IgM, and IgA antibod-
ies against C. burnetii phase II antigen by using indirect
immunofluorescent antibody (IFA) test with a commer-
cial kit (bioMerieux, Lyon, France). According to the test
guidelines, IgG antibodies were accepted positive in case
of > or = 1:60 titre, while IgM and IgA antibodies in case
of > or = 1:25 titre [6].
The geographical information system was used on a
regional level [7]. Information on risk factors was col-
lected from the participants and the animal owners. The
issues of the first phase were to detect clinical cases of Q
fever, to isolate C. burnetii by shell vial technique and to
assess the clinical spectrum of the disease in "high risk"
region.
Following the detection of seropositive humans and ani-
mals in the "high risk" region, trained physicians followed
all of the seronegative individuals up for one year on a
monthly basis to detect clinical cases of Q fever. All the
suspected cases of Q fever during the first year of follow up
were examined serologically by IFA and attempts were
made to isolate C. burnetii in confirmed cases. Detection
of acute cases of Q fever was based on specific clinical and
laboratory criteria. Acute C. burnetii infection was diag-
nosed on the basis of the association of (i) fever (38°C);
with at least two other symptoms (chills, headache, myal-
gias, atypical pneumonia, and/or elevated hepatic
transaminase levels) and with exhibition of a phase II
immunoglobulin G (IgG) titre > = 1:240 and an IgM of >
= 1:50 when only one serum specimen was available or a
seroconversion when two sera sampled two or more
weeks apart were available [8,9]. At the end of the follow
up period, all participants were tested by IFA for identifi-
cation of additional seroconversions even without overt
clinical symptoms.
Active surveillance of Q fever in the entire island of Cyprus
During the second phase of the study, an active surveil-
lance of Q fever for one additional year in the whole
human and animal population of Cyprus was conducted
using the same methodology. All physicians in hospitals,BMC Infectious Diseases 2006, 6:48 http://www.biomedcentral.com/1471-2334/6/48
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health care centers and private medical facilities, in
Cyprus, were asked to report suspected cases. As with the
first phase, the total number of suspected cases was sero-
logically examined by IFA and attempts were made to iso-
late C. burnetii via shell vial technique, in confirmed cases.
Buffy coat inoculated on shell vials, which contained
monolayers of Vero cells, and they were centrifuged at 700
× g for 1 h at 22°C. The inoculum was then removed and
1 ml of growth medium was added to the cells. The shell
vials were incubated in a 5% CO2 incubator at 37°C. At
the same time, two shell vials were inoculated with Mini-
mal Essential Medium (MEM) and used as negative con-
trols. The isolation of C. burnetii was carried out in a
biosafety cabinet used only for shell vial infection. The
cell monolayers in the shell vials were examined for C.
burnetii by the IFA technique on day 6 and if the first test
was negative, again on day 12 [10].
Active surveillance of Q fever in animal population of
Cyprus was also conducted during the same study period.
All the state and private veterinarians were asked to report
to the veterinary services all the abortions and submit
blood samples to be tested at the veterinary services labo-
ratory. The IFA technique was used with a cut off point of
IgG > = 1:240 and Igm> = 50. Moreover an effort was
made to isolate C. burnetii via shell vial technique, in con-
firmed cases.
Statistical analysis
Statistical analysis was performed using SPSS 11.0 and
Epi-info 2002 software. We used chi-square for compari-
son of qualitative data and t-test or the non parametric
mann-Whitney test for comparison of quantitative data.
Results
Active surveillance of Q fever in "high risk" region
Out of the total population in both villages under study,
79 individuals from VIL1 (response rate 52.46%) and 121
from VIL2 (response rate 61.8%) agreed to participate in
the study. Fifteen participants from VIL1 (19%) and 21
from VIL2 (18%) were children. Ten percent of the ani-
mals owned by the participants were randomly sampled.
Fifty five goats and 119 sheep were tested from VIL1 and
46 goats, 137 sheep and 26 bovine from VIL2.
The seropositivity of the inhabitants of VIL1  was esti-
mated at 59.5% (47 individuals) using 1:60 titre as a cut-
off point for IgG antibodies and at 52.9% (64 individuals)
for the population of VIL2. The seropositivity was related
to the participants' age. The mean age of seropositive par-
ticipants was 44.7 years compared with 33.5 for seroneg-
ative and the difference was statistically significant (p <
0.05).
Seropositivity in children was 27.8% (10 out of the 36)
and was significantly lower (RR = 0.46, p < 0.005) than
the seropositivity of adults 61.6% (101 out of the 164).
The animal seropositivity was correlated with the seropos-
itivity of humans and was higher in VIL1 (75/174, 43.1%)
than the animal seropositivity in VIL2 (60/209,
28.7%)using 1:60 titre as a cut off point for IgG antibodies
(RR = 1.50, p < 0.005). The human seropositivity was
related to animal contact (RR = 2.54, p < 0.0001). The
relation was even stronger when the contact was with tick-
infested animals (RR = 2.82, p < 0.0001).
Thirty two seronegative people for C. burnetii from VIL1
and 57 from VIL2 were followed up for one year on a
monthly basis by trained physicians. Eight out of a total of
89 people were lost to follow up and finally 81 inhabit-
ants actually participated in the follow up. Nineteen out
of the 81 participants were children less than 15 years old.
Thirteen suspected cases of Q fever were detected in both
villages whereas only two cases were confirmed by labora-
tory testing (2.41%) representing an incidence rate of 5.7
per 1000 inhabitants of the specific region per year. Both
cases detected in the "high risk" region were adults with
mild symptoms treated as outpatients with favorable out-
come.
Serological tests among the seronegatives at the end of the
annual surveillance period revealed 36 new seropositive
Table 1: Seropositivity for C. burnetii in the "high risk" region of Cyprus before and after the surveillance period
Before After










Humans 200 111 (55.5) 81* 13 2 20 (25.3) 36 (44.4)
Animals
Goats 101 52 (51.4) 45 3 1 6 (13.3) 10 (22.2)
Sheep 256 65 (25.3) 175 4 - 17 (9.7) 21 (12)
Bovine 26 5 (19.2) 19 - - 1 (5.2) 2 (10.5)
Total 
(animals)
383 122 (31.8) 239 ** 7 1 24 (10) 33 (13.8)BMC Infectious Diseases 2006, 6:48 http://www.biomedcentral.com/1471-2334/6/48
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out of the 81 participants (44.4%) using 1/60 titre as a
cutoff point for IgG antibodies while 20 residents (25.3%)
were found positive for IgG antibodies using 1:120titre.
Moreover, 19 participants (24.8%) were found positive
for IgM antibodies using 1:25titre as a cutoff point. Six
new seropositives were identified among the 19 (31.5%)
participating children while 30 new seropositives were
identified among the 62 (48.3%) participating adults (RR
= 0.65, p = 0.30). The rate of acute Q fever cases versus the
seropositives in the "high risk" region was estimated at
5.2% (2/38) using the 1:60 titre as a cutoff point and
9.09% (2/22) using the 1:120 titre as a cutoff point.
Forty five goats, 175 sheep and 19 bovine out of the total
seronegative animal population in both villages were
included in the active surveillance program. Although
seven suspected cases of Q fever (3 goats and 4 sheep)
were identified, from which only one goat was serologi-
cally confirmed, the percentage of new seropositive ani-
mals in the end of the year was 13.8% (33 new
seropositive animals using 1:60 titre for IgG antibodies).
The rate of acute Q fever animal cases versus the seropos-
itive animals in the "high risk" region was estimated at
2.9% (1/34). In Table 1 the results from the annual sur-
veillance period of Q fever in the two villages of Cyprus
are presented.
Active surveillance of Q fever in the entire island of Cyprus
The population of Cyprus is approximately 700,000 and
the island has five major public hospitals in the capital of
Nicosia and the other major cities of the island. The spe-
cific case definition criteria of Q fever, was distributed to
all public hospitals, rural health care centers (approxi-
mately 30) and private health care facilities. Approxi-
mately, 200 primary care physicians were notified about
the surveillance program. During one year of active sur-
veillance in the entire island, 82 suspected cases were
identified. Following laboratory examination, only nine
cases were confirmed and C. burnetii was isolated from
three human blood samples by shell vial technique. The
incidence rate of Q fever in humans in Cyprus for this
period of active surveillance was estimated at 1.2 per
100,000 inhabitants per year. The incidence rate in rural
areas was estimated at 3.21 per 100,000 per year (7/
218,000) and was higher of the estimated incidence rate
in urban areas (0.41 per 100,000 per year, 2/482,000, RR
= 7.74, p < 0.005). No sex difference was identified (5
males and 4 females). One out of the nine cases was a
child l2 years old representing an incidence rate of 0.41
per 100,000 children per year while 8 cases were adults
representing an incidence rate of 1.61 per 100000 adults
per year (RR = 0.3, p = 0.4). Moreover all cases but one
reported animal contact (goat or sheep).
The animal population of Cyprus during the study period
was estimated at 374,000 animals (180,000 goats,
190,000 sheep and 4,000 bovines). One hundred goats
and 76 sheep were reported to the Ministry of Agriculture
as suspected cases of Q fever, however only 8 goats and 4
sheep were serologically confirmed during the one-year
study period. C. burnetii was isolated from two goat blood
samples by shell vial technique.
Discussion
During an active surveillance program of Q fever in a
"high risk" region of Cyprus (villages Kotsiatis and Para-
mali), among 81 seronegative participants who were fol-
lowed-up on a monthly basis by trained physicians,
thirteen individuals were clinically suspected for Q fever
and only two of them were serologically confirmed as
acute cases. Surprisingly, in the end of the year, 36 new
IgG seropositive individuals for C. burnetii were detected
(44.4%). If the seropositives together with the cases are
regarded as exposed to C. burnetii then the estimated
attack rate is 5.2% and the ratio among asymptomatic ver-
sion symptomatic cases is 18, which is considered very
high. The incidence rate (5.7/1000/year) in this "high
risk" region was relatively high compared with other
endemic regions worldwide [11-14] but it should be
noted that this is a result of monthly follow up. Under the
routine primary health care provision and surveillance,
these two cases of Q fever with mild symptoms might not
be diagnosed or reported. The estimated attack rate
(5.2%) is very small compared with attack rates estimated
during outbreak investigations in other endemic countries
witch are reported up to 65% [11]. In the same region's
animal population, among 239 seronegative animals, 7
suspected cases were identified and one was serologically
confirmed. However, at the end of the year 33 new serop-
ositive animals (13.8%) were detected. The attack rate
among the animal population was estimated at 2.9%. The
above findings supports that the exposure to C. burnetii in
this specific region is high and that the majority of cases
in the local population, appear to be subclinical. In a pre-
vious study in Cyprus C. burnetii was isolated in 7.8% of
collected ticks by using shell vial technique [15]. Some
authors suggest that in nature, C. burnetii is found prima-
rily in a cycle involving ticks and free-living vertebrates
and ticks play a significant role in the transmission of C.
burnetii among the wild vertebrates, especially in rodents,
lagomorphs, and wild birds. Other authors suggest that
ticks transmit the agent not only to wild animals, but also
to domestic animals (creating the livestock reservoir of C.
burnetii) [1,16]. From our data and the previous study on
ticks we could generate a hypothesis that ticks are related
to seropositivity in both animals and humans but possi-
bly not with human acute cases. This hypothesis should
be further investigated by analytical epidemiological stud-
ies.BMC Infectious Diseases 2006, 6:48 http://www.biomedcentral.com/1471-2334/6/48
Page 5 of 6
(page number not for citation purposes)
During an additional year of active surveillance in the
entire island of Cyprus, only nine cases of Q fever human
cases were serologically confirmed representing a rela-
tively small incidence rate (1.2 per 100000 per year) com-
pared to other endemic countries[11-14]. In Australia the
incidence rate was estimated 30–60 cases per 100,000 per
year in endemic regions while in Spain was estimated 5–
10 cases per 100,000 per year. Comparing the incidence
rate of Cyprus with other endemic countries we should
take into consideration the fact that it was estimated after
active surveillance. Both seropositivity and incidence rate
of Q fever in Cyprus were lower in Children compared
with adults. This finding supports the speculation of other
researchers that children are less frequently symptomatic
than adults following infection, and may have milder dis-
ease [17].
In endemic countries the diagnosis must be considered in
the case of an unexplained fever, especially if the fever
recurred following contact with possibly contaminated
mammals. The besttests for diagnosis are those, which per-
mit the direct detection of the bacteria. They include shell
vial cell culture, PCR amplification, and immunodetec-
tion with tissue biopsy specimens. All these techniques
require a level3 biosafety laboratory and trained person-
nel due to the extreme infectivity of C. burnetii. As for indi-
rect specific diagnosis, the technique to be used should be
very sensitive and should detect antibodies early in the
course of the disease. In most of the countries serological
diagnosis with IFA remains the only reliable alternative
taking into consideration the problems with cutoff point
values and the quality and standardization of the antigens
[18,19].
Consequently, during the active surveillance for animal
cases 12 animals were serologically confirmed and C. bur-
netii was isolated from one goat blood sample by shell vial
technique. In the previous 6 years zero to one case were
reported each year. This finding indicates that Q fever has
been underreported in the past in the animal population
of Cyprus either because the disease was not suspected or
because there was no suitable laboratory network availa-
ble.
It is important to point out that, unlike Cyprus, outbreaks
of Q fever are often detected and investigated in other
European countries where also high seroprevalence for C.
burnetii is observed. In Vicenza (north eastern Italy), an
outbreak of Q fever with 58 patients was detected, within
a 5-month period, after exposure to three flocks of sheep
that passed through the outbreak area [20]. Another large
outbreak of Q fever, involving 415 serologically con-
firmed cases, was described in the Val de Bagnes (Switzer-
land) in 1983 [21]. In the island of Crete, in Greece, and
in Marseille, France, 98 cases of acute Q fever over a five-
year period, and 323 cases over an eight year period were
identified, respectively [22,23].
Another observation from our study is that, in Cyprus as
opposed to other countries, goats have the highest serop-
ositivity for C. burnetii and are most often implicated in Q
fever cases, whereas Q fever outbreaks are caused mainly
from direct or indirect exposure to sheep flocks [24-27].
Moreover, although many Q fever cases, recently reported,
were acquired from exposure to parturient cats [28,29],
such correlation in Cyprus was not observed.
Our study suggests that due to the high prevalence of sero-
positivity in the human and animal population of Cyprus
and the high proportion of subclinical cases in humans,
active surveillance for the disease may be warranted in
order to identify animal sources and control the transmis-
sion to the human population. Moreover, foreigners, who
may not have immunity against C. burnetii, might be vul-
nerable to the disease as suggested by the level of seropos-
itivity (2.7%) in Swedish soldiers serving in Cyprus in
1975 and 1976 [30] and the large number of Q fever cases
in 1974 among British soldiers [5].
Conclusion
The study shows that a large percentage of the population
in Cyprus is seropositive to C. burnetii and that the major-
ity of Q fever cases in the local population do not present
with clinically overt symptoms. Therefore, people who get
infected with C. burnetii are most often subclinical cases
that neither are identified nor are reported. Moreover fur-
ther studies should investigate the role of ticks in the epi-
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